ZEEBRA THERAPY LTD

Executive Summary

ZEEBRA THERAPY LTD is a micro-entity in early development showing improving financial health with increasing assets and elimination of current liabilities by 2024. However, significant provisions for liabilities and absence of employees present operational and solvency risks that warrant further investigation. The company demonstrates compliance with filing obligations, supporting governance reliability.

ZEEBRA THERAPY LTD - Analysis Report

Company Number: 14034485

Analysis Date: 2025-07-20 18:57 UTC

1. Risk Rating: MEDIUM

The company shows early-stage financial recovery with positive net assets but also some liabilities and provisions that could impact solvency. The lack of employees and limited asset base suggests a small-scale operation with inherent operational risks.

2. Key Concerns:

• Provisions for liabilities are significant (£7,216 as of 2024) relative to the company's size and shareholders' funds, potentially indicating expected future outflows or contingent risks.
• No employees are reported, which may raise questions about operational capacity and sustainability of service delivery in a human health-related activity.
• Negative shareholders' funds in prior years (2022 and 2023) indicate historical losses or capital deficiencies, which though improved in 2024, suggest a fragile financial foundation.

3. Positive Indicators:

• Current liabilities have been fully settled as of 2024, improving liquidity position (current liabilities dropped from £3,119 in 2023 to £0 in 2024).
• Increase in current assets from £7,753 in 2023 to £11,550 in 2024 shows growing asset base and potential improved cash or receivables position.
• Timely filings and no overdue accounts or confirmation statements reflect good regulatory compliance and governance practices.

4. Due Diligence Notes:

• Investigate the nature and expected timing of the provisions for liabilities to assess solvency risks.
• Clarify how the company operates without employees—are services outsourced or is the director providing all operational functions?
• Review cash flow statements if available to confirm liquidity sustainability and assess working capital management.
• Confirm whether the director's dual role as secretary impacts governance and compliance effectiveness.
• Verify whether the company has any contingent liabilities or off-balance sheet obligations not reflected in the accounts.